Scientists hunt for early warning signs in rare lung disease

NCT ID NCT05297812

First seen Jan 18, 2026 · Last updated Apr 11, 2026 · Updated 11 times

Summary

This study aims to understand why some people with Alpha-1 antitrypsin deficiency, a genetic lung and liver disease, get worse quickly while others stay stable. Researchers will follow 286 patients for three years, using CT scans and blood tests to look for early signs that predict rapid lung decline. The goal is to find better markers for future drug trials, as current lung function tests don't always show disease progression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Boston University

    Boston, Massachusetts, 02118, United States

  • Columbia University

    New York, New York, 10032, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • National Jewish Health

    Denver, Colorado, 80206, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35233, United States

  • University of California - Los Angeles

    Los Angeles, California, 90095, United States

  • University of Chicago

    Chicago, Illinois, 60637, United States

  • University of North Carolina

    Chapel Hill, North Carolina, 27514, United States

  • University of Utah

    Salt Lake City, Utah, 84108, United States

Conditions

Explore the condition pages connected to this study.